Effects of 15-deoxy-Δ12,14-PGJ2 on B lineage cells

被引：0
|
作者：
Padilla, J
Kaur, K
Phipps, RP
机构：
[1] Univ Rochester, Dept Microbiol & Immunol, Rochester, NY 14642 USA
[2] Univ Rochester, Ctr Canc, Rochester, NY 14642 USA
[3] Univ Rochester, Eastman Dent Ctr, Rochester, NY 14642 USA
来源：
LYSOPHOSPHOLIPIDS AND EICOSANOIDS IN BIOLOGY AND PATHOPHYSIOLOGY | 2000年 / 905卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：322 / 325
页数：4
相关论文
共 50 条
  • [31] Peroxisome proliferator-activated receptors alpha and beta mediate the anti-inflammatory effects of the cyclopentenone prostaglandin 15-deoxy-?12,14-PGJ2 in fish granulocytes
    Gomez-Abellan, Victoria
    Perez-Oliva, Ana B.
    Cabas, Isabel
    Hermi, Fatma
    Arizcun, Marta
    Garcia-Moreno, Diana
    Sepulcre, Maria P.
    Mulero, Victoriano
    [J]. DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 2022, 136
  • [32] 15-deoxy-Δ12,14PGJ2 induces diverse biological responses via PPARγ activation in cancer cells
    Clay, CE
    Namen, AM
    Fonteh, AN
    Atsumi, G
    High, KP
    Chilton, FH
    [J]. PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2000, 62 (01): : 23 - 32
  • [33] Regulation of proinflammatory cytokines in human gestational tissues by peroxisome proliferator-activated receptor-γ:: Effect of 15-deoxy-Δ12,14-PGJ2 and troglitazone
    Lappas, M
    Permezel, M
    Georgiou, HM
    Rice, GE
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (10): : 4667 - 4672
  • [34] 15-deoxy-Δ12,14_PGJ2:: endogenous PPARγ ligand or minor eicosanoid degradation product?
    Powell, WS
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (06): : 828 - 830
  • [35] Interleukin-6 Synthesis in Human Chondrocytes Is Regulated via the Antagonistic Actions of Prostaglandin (PG)E2 and 15-deoxy-Δ12,14-PGJ2
    Wang, Pu
    Zhu, Fei
    Konstantopoulos, Konstantinos
    [J]. PLOS ONE, 2011, 6 (11):
  • [36] Effects of 15-Deoxy-Δ12,14-Prostaglandin J2 (15d-PGJ2) and Rosiglitazone on Human Vδ2+ T Cells
    Li, Haishan
    Pauza, C. David
    [J]. PLOS ONE, 2009, 4 (11):
  • [37] Quantitative Targeted Metabolomics for 15d-deoxy-Δ12,14-PGJ2 (15dPGJ2) by MALDI-MS
    Kim, Kyoung-Jin
    Park, Han-Gyu
    Hwang, Cheol-Hwan
    Ann, Da-Hee
    Song, Won-Suk
    Choi, Kwon-Young
    Yang, Yung-Hun
    Park, SangYoun
    Kim, Yun-Gon
    [J]. BIOTECHNOLOGY AND BIOPROCESS ENGINEERING, 2017, 22 (01) : 100 - 106
  • [38] Response to letter by Tsikas et al. 15-deoxy-Δ12,14-PGJ2: An interesting but unapproachable pharmacological target? (vol 177, pg 307, 2014)
    Tsikas, Dimitrios
    Niemann, Jonas
    Beckmann, Bibiana
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 191 : 322 - 322
  • [39] Peroxisome proliferator activator receptor-γ (PPARγ) ligands, 15-deoxy-Δ12,14-PGJ2 (15D-PGJ2) and ciglitazone, provide cardioprotection during reperfusion through different molecular mechanisms.
    Zingarelli, B
    Hake, PW
    O'Connor, M
    Burroughs, TJ
    Denenberg, A
    [J]. SHOCK, 2004, 21 : 62 - 62
  • [40] Inhibition of macrophage mediator production by the prostaglandin J2 (PGJ2) metabolite:: 15-deoxy-Δ12,14 PGJ2
    Guyton, K
    Bond, R
    Ashton, S
    Tempel, G
    Wise, C
    Halushka, PV
    Cook, JA
    [J]. SHOCK, 1999, 11 : 41 - 41
12345